HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK.

AbstractOBJECTIVES:
To assess the applicability of risk factors for severe COVID-19 defined in the general population for patients on haemodialysis.
SETTING:
A retrospective cross-sectional study performed across thirty four haemodialysis units in midlands of the UK.
PARTICIPANTS:
All 274 patients on maintenance haemodialysis who tested positive for SARS-CoV-2 on PCR testing between March and August 2020, in participating haemodialysis centres.
EXPOSURE:
The utility of obesity, diabetes status, ethnicity, Charlson Comorbidity Index (CCI) and socioeconomic deprivation scores were investigated as risk factors for severe COVID-19.
MAIN OUTCOMES AND MEASURES:
Severe COVID-19, defined as requiring supplemental oxygen or respiratory support, or a C reactive protein of ≥75 mg/dL (RECOVERY trial definitions), and its association with obesity, diabetes status, ethnicity, CCI, and socioeconomic deprivation.
RESULTS:
63.5% (174/274 patients) developed severe disease. Socioeconomic deprivation associated with severity, being most pronounced between the most and least deprived quartiles (OR 2.81, 95% CI 1.22 to 6.47, p=0.015), after adjusting for age, sex and ethnicity. There was no association between obesity, diabetes status, ethnicity or CCI with COVID-19 severity. We found no evidence of temporal evolution of cases (p=0.209) or clustering that would impact our findings.
CONCLUSION:
The incidence of severe COVID-19 is high among patients on haemodialysis; this cohort should be considered high risk. There was strong evidence of an association between socioeconomic deprivation and COVID-19 severity. Other risk factors that apply to the general population may not apply to this cohort.
AuthorsHaresh Selvaskandan, Katherine L Hull, Sherna Adenwalla, Safa Ahmed, Maria-Cristina Cusu, Matthew Graham-Brown, Laura Gray, Matt Hall, Rizwan Hamer, Ammar Kanbar, Hemali Kanji, Mark Lambie, Han Sean Lee, Khalid Mahdi, Rupert Major, James F Medcalf, Sushiladevi Natarajan, Boavojuvie Oseya, Stephanie Stringer, Matthew Tabinor, James Burton
JournalBMJ open (BMJ Open) Vol. 12 Issue 5 Pg. e054869 (05 30 2022) ISSN: 2044-6055 [Electronic] England
PMID35636784 (Publication Type: Journal Article, Multicenter Study)
Copyright© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Topics
  • COVID-19 (epidemiology)
  • Cross-Sectional Studies
  • Diabetes Mellitus (epidemiology)
  • Humans
  • Obesity (epidemiology)
  • Renal Dialysis
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • United Kingdom (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: